| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $687.8M | +2.2% |
| Cost of Revenue | $306.5M | +4.4% |
| Gross Profit | $381.3M | +0.4% |
| R&D Expense | $26.2M | -3.7% |
| SG&A Expense | $318.5M | -4.9% |
| Operating Income | -$396.2M | -9533.3% |
| Pre-tax Income | -$403.3M | -5005.1% |
| Income Tax | -$17.0M | -950.0% |
| Net Income | -$392.1M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $107.7M | +22.8% |
| Accounts Receivable | $132.8M | -7.0% |
| Inventory | $138.8M | -15.0% |
| Current Assets | $393.4M | -19.2% |
| Total Assets | $1.15B | -31.8% |
| Current Liabilities | $165.9M | -29.3% |
| Long-term Debt | $125.3M | -21.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $100.7M | +210.8% |
| Investing Cash Flow | -$27.5M | -227.3% |
| Financing Cash Flow | -$49.1M | +47.9% |
| -534.5% |
| EPS (Basic) | -$8.53 | -546.2% |
| EPS (Diluted) | -$8.53 | -546.2% |
| Total Liabilities |
| $325.7M |
| -28.6% |
| Stockholders' Equity | $828.5M | -33.0% |